Molecular and Genomics Core Facility
The UMMC Molecular and Genomics Core Facility (MGCF) is supported through several extramural funding mechanisms, including 2 large Center grants, NIH-R01 awards, and through the Department of Pharmacology. This allows us to provide highly competitive prices to institutional and external researchers in Mississippi wanting to conduct genetic and genomic studies.
The CMDRC provides infrastructure for a multidisciplinary group of basic, clinical and population scientists working on the common theme of obesity, cardiorenal and metabolic diseases and to facilitate their collaborations.
Cardiorenal and metabolic diseases are the leading causes of mortality and morbidity in the U.S., and Mississippi has the highest prevalence in the nation. These disorders usually cluster and are highly interdependent. For example, obesity and associated diabetes may cause cardiovascular and renal disease.
Mississippi IDeA Network of Biomedical Research Excellence (INBRE) is a network of colleges and universities, designed to build a biomedical research infrastructure in Mississippi. Our mission is to reach out to Mississippians in order to improve health throughout the state and to engage talented researchers and students in biomedical research projects that will increase the state’s research competitiveness as well as impact the health of citizens of Mississippi. The scientific focus of Mississippi INBRE is obesity, cancer and sexually transmitted diseases.
For those researchers that have utilized the MGCF in the past or plan to in the future, please remember to cite the below funding acknowledgement in oral or poster presentations and most importantly when submitting a manuscript for publication. The main measure of productivity for the MGCF is through publications. All grants need to be included (not just those you may be directly associated with) as without the support of all these funding sources the MGCF would not have sufficient resources to function.
“The work performed through the UMMC Molecular and Genomics Facility is supported, in part, by funds from the NIGMS, including Mississippi INBRE (P20GM103476) and Obesity, Cardiorenal and Metabolic Diseases- COBRE (P20GM104357). The content of the manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”